$HQY
HEALTHEQUITY, INC. Stock $hqy

$hqy Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-K Financial Statement

#000142833622000009 Filed on March 31, 2022

Income Statement

Concept	2022 Q1	2022	2021 Q1
Revenue	$203.3M	$756.6M	$188.2M
YoY Change	8.02%	3.13%	-6.46%
Cost Of Revenue	$98.00M	$332.9M	$87.30M
YoY Change	12.25%	4.59%	-0.25%
Gross Profit	$105.3M	$423.7M	$100.9M
YoY Change	4.36%	2.02%	-11.24%
Gross Profit Margin	51.8%	56.0%	53.61%
Selling, General & Admin	$37.19M	$143.0M	$36.40M
YoY Change	2.18%	6.34%	-2.41%
% of Gross Profit	35.32%	33.75%	36.08%
Research & Development	$45.93M	$157.4M	$32.30M
YoY Change	42.19%	26.08%	2.54%
% of Gross Profit	43.62%	37.14%	32.01%
Depreciation & Amortization	$38.82M	$137.2M	$30.40M
YoY Change	27.71%	18.36%	14.29%
% of Gross Profit	36.87%	32.38%	30.13%
Operating Expenses	$106.2M	$447.9M	$87.80M
YoY Change	20.92%	17.47%	-11.44%
Operating Profit	-$867.0K	-$24.24M	$13.10M
YoY Change	-106.62%	-171.26%	-9.92%
Interest Expense	-$10.65M	$36.57M	-$6.600M
YoY Change	61.38%	4.85%	-51.47%
% of Operating Profit			-50.38%
Other Income/Expense, Net	$51.00K	-$42.50M	$7.900M
YoY Change	-99.35%	42.27%	-152.15%
Pretax Income	-$43.77M	-$66.74M	-$1.300M
YoY Change	3266.54%	-1712.1%	116.67%
Income Tax	-$10.95M	-$22.45M	-$6.700M
% Of Pretax Income
Net Earnings	-$32.82M	-$44.29M	$5.400M
YoY Change	-707.74%	-601.35%	-2942.11%
Net Earnings / Revenue	-16.14%	-5.85%	2.87%
Basic Earnings Per Share		-$0.53
Diluted Earnings Per Share	-$392.0K	-$0.53	$68.61K
COMMON SHARES
Basic Shares Outstanding	83.82M shares	83.13M shares	83.02M shares
Diluted Shares Outstanding		83.13M shares

Balance Sheet

Concept	2022 Q1	2022	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$225.4M	$225.4M	$328.8M
YoY Change	-31.44%	-31.44%	71.52%
Cash & Equivalents	$225.4M	$225.4M	$328.8M
Short-Term Investments
Other Short-Term Assets	$38.50M	$38.50M	$58.61M
YoY Change	-34.32%	-34.31%	68.84%
Inventory
Prepaid Expenses
Receivables	$87.43M	$87.43M	$72.77M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$351.3M	$351.3M	$460.2M
YoY Change	-23.65%	-23.66%	54.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.37M	$86.99M	$29.11M
YoY Change	-19.7%	-26.66%	-13.08%
Goodwill	$1.646B		$1.327B
YoY Change	24.01%		-0.41%
Intangibles	$973.1M		$767.0M
YoY Change	26.88%		-2.08%
Long-Term Investments
YoY Change
Other Assets	$49.81M	$49.81M	$37.42M
YoY Change	33.1%	33.17%	6.64%
Total Long-Term Assets	$2.756B	$2.756B	$2.250B
YoY Change	22.47%	22.47%	-0.77%
TOTAL ASSETS
Total Short-Term Assets	$351.3M	$351.3M	$460.2M
Total Long-Term Assets	$2.756B	$2.756B	$2.250B
Total Assets	$3.107B	$3.107B	$2.710B
YoY Change	14.64%	14.64%	5.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$27.54M	$27.54M	$1.614M
YoY Change	1606.38%	1621.31%	-59.45%
Accrued Expenses	$57.59M	$116.9M	$75.88M
YoY Change	-24.11%	-16.86%	63.63%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$8.750M	$8.750M	$62.50M
YoY Change	-86.0%	-86.0%	60.0%
Total Short-Term Liabilities	$153.2M	$153.2M	$204.7M
YoY Change	-25.17%	-25.17%	34.73%
LONG-TERM LIABILITIES
Long-Term Debt	$922.1M	$922.1M	$924.2M
YoY Change	-0.23%	-0.23%	-21.78%
Other Long-Term Liabilities	$14.19M	$79.42M	$8.808M
YoY Change	61.05%	-4.32%	235.54%
Total Long-Term Liabilities	$1.101B	$1.001B	$1.127B
YoY Change	-2.27%	-0.57%	-18.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$153.2M	$153.2M	$204.7M
Total Long-Term Liabilities	$1.101B	$1.001B	$1.127B
Total Liabilities	$1.255B	$1.255B	$1.332B
YoY Change	-5.79%	-5.8%	-13.23%
SHAREHOLDERS EQUITY
Retained Earnings	$176.1M		$220.3M
YoY Change	-20.1%		4.18%
Common Stock	$8.000K		$8.000K
YoY Change	0.0%		14.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.853B	$1.853B	$1.379B
YoY Change
Total Liabilities & Shareholders Equity	$3.107B	$3.107B	$2.710B
YoY Change	14.64%	14.64%	5.67%

Cashflow Statement

Concept	2022 Q1	2022	2021 Q1
OPERATING ACTIVITIES
Net Income	-$32.82M	-$44.29M	$5.400M
YoY Change	-707.74%	-601.35%	-2942.11%
Depreciation, Depletion And Amortization	$38.82M	$137.2M	$30.40M
YoY Change	27.71%	18.36%	14.29%
Cash From Operating Activities	$50.56M	$141.0M	$60.90M
YoY Change	-16.98%	-22.37%	97.09%
INVESTING ACTIVITIES
Capital Expenditures	-$16.30M	$8.908M	-$20.30M
YoY Change	-19.7%	-31.96%	91.51%
Acquisitions		$504.5M
YoY Change
Other Investing Activities	-$455.0M	-$502.2M	$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$471.3M	-$639.2M	-$20.30M
YoY Change	2221.68%	559.26%	-19.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$456.6M
YoY Change		59.23%
Debt Paid & Issued, Net		$1.003B
YoY Change		319.61%
Cash From Financing Activities	-2.971M	$394.9M	-11.20M
YoY Change	-73.47%	653.24%	-199.12%
NET CHANGE
Cash From Operating Activities	50.56M	$141.0M	60.90M
Cash From Investing Activities	-471.3M	-$639.2M	-20.30M
Cash From Financing Activities	-2.971M	$394.9M	-11.20M
Net Change In Cash	-423.7M	-$103.4M	29.40M
YoY Change	-1541.21%	-175.42%	71.93%
FREE CASH FLOW
Cash From Operating Activities	$50.56M	$141.0M	$60.90M
Capital Expenditures	-$16.30M	$8.908M	-$20.30M
Free Cash Flow	$66.86M	$132.1M	$81.20M
YoY Change	-17.66%	-21.62%	95.66%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001428336
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-01-31
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-36568
CY2022	dei	Entity Registrant Name EntityRegistrantName	HEALTHEQUITY, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-2383166
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	15 West Scenic Pointe Drive
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Draper
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84020
CY2022	dei	City Area Code CityAreaCode	801
CY2022	dei	Local Phone Number LocalPhoneNumber	727-1000
CY2022	dei	Security12b Title Security12bTitle	Common stock, par value $0.0001 per share
CY2022	dei	Trading Symbol TradingSymbol	HQY
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q3	dei	Entity Public Float EntityPublicFloat	6100000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	83821764	shares
CY2022	dei	Auditor Firm AuditorFirmId	238
CY2022	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2022	dei	Auditor Location AuditorLocation	Salt Lake City, Utah
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	225414000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	328803000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6228000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4239000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	87428000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	72767000	USD
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	38495000	USD
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	58607000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	351337000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	460177000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23372000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29106000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	63613000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	89508000	USD
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	973137000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	767003000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	1645836000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	1327193000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	49807000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	37420000	USD
CY2022Q1	us-gaap	Assets Assets	3107102000	USD
CY2021Q1	us-gaap	Assets Assets	2710407000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	27541000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1614000	USD
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	47136000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	50670000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	57589000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	75880000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	8750000	USD
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	62500000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12171000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14037000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	153187000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	204701000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	922077000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	924217000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	65232000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	74224000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14185000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8808000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	99846000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	119729000	USD
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1101340000	USD
CY2021Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1126978000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	1254527000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	1331679000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	83780000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	83780000	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	77168000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	77168000	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3107102000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2710407000	USD
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	332850000	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1676508000	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1158372000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	176059000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	220348000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1852575000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1378728000	USD
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	756556000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	733570000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	531993000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	318236000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	206084000	USD
CY2022	us-gaap	Gross Profit GrossProfit	423706000	USD
CY2021	us-gaap	Gross Profit GrossProfit	415334000	USD
CY2020	us-gaap	Gross Profit GrossProfit	325909000	USD
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	58605000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	49964000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	43951000	USD
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	157364000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	124809000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	77576000	USD
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	84379000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	84493000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	60561000	USD
CY2022	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	82791000	USD
CY2021	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	76064000	USD
CY2020	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	34704000	USD
CY2022	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	64805000	USD
CY2021	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	45990000	USD
CY2020	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	32111000	USD
CY2022	us-gaap	Operating Expenses OperatingExpenses	447944000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	381320000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	248903000	USD
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-24238000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	34014000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	77006000	USD
CY2022	us-gaap	Interest Expense InterestExpense	36572000	USD
CY2021	us-gaap	Interest Expense InterestExpense	34881000	USD
CY2020	us-gaap	Interest Expense InterestExpense	24772000	USD
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5931000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5007000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9079000	USD
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-42503000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-29874000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-33851000	USD
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-66741000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4140000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	43155000	USD
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-22452000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4694000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3491000	USD
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-44289000	USD
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-44289000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8834000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	8834000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	39664000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	39664000	USD
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83133000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74235000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67026000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	83133000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75679000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	68453000	shares
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	477079000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11438000	USD
CY2020	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	462270000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39844000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	39664000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	1030295000	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	9956000	USD
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	286780000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	42863000	USD
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8746000	USD
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	456640000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	8834000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1378728000	USD
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	52750000	USD
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-44289000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1852575000	USD
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-44289000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	8834000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	39664000	USD
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	137188000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	115904000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	55352000	USD
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	52750000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	42863000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	39844000	USD
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	11246000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-728000	USD
CY2021	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	USD
CY2020	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	USD
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4448000	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5102000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2711000	USD
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4049000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2147000	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	1677000	USD
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2020	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	27570000	USD
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1232000	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1753000	USD
CY2022	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-23430000	USD
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-5132000	USD
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	3665000	USD
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11204000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	413000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4029000	USD
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-7464000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	24839000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	12577000	USD
CY2022	hqy	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-15235000	USD
CY2021	hqy	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-11150000	USD
CY2020	hqy	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-6218000	USD
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3657000	USD
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	771000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4550000	USD
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2178000	USD
CY2020	us-gaap	Payments For Software PaymentsForSoftware	25654000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	30422000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1920000	USD
CY2022	hqy	Increase Decrease In Operating Lease Liability Noncurrent IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent	-9412000	USD
CY2021	hqy	Increase Decrease In Operating Lease Liability Noncurrent IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent	-10803000	USD
CY2020	hqy	Increase Decrease In Operating Lease Liability Noncurrent IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent	-5383000	USD
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	5377000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	6007000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-83000	USD
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	140995000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	181619000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	105010000	USD
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	504533000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1644575000	USD
CY2022	us-gaap	Payments For Software PaymentsForSoftware	62708000	USD
CY2021	us-gaap	Payments For Software PaymentsForSoftware	51500000	USD
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	65465000	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	32371000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	9134000	USD
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8908000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13093000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7286000	USD
CY2022	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	53845000	USD
CY2022	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	2367000	USD
CY2021	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	0	USD
CY2020	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	0	USD
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-639247000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-96964000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1740494000	USD
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1003125000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	458495000	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	239063000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7813000	USD
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	950000000	USD
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1250000000	USD
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11920000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	30504000	USD
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	456640000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	286779000	USD
CY2022	hqy	Payments To Settle Client Held Funds PaymentsToSettleClientHeldFunds	486000	USD
CY2021	hqy	Payments To Settle Client Held Funds PaymentsToSettleClientHeldFunds	3862000	USD
CY2020	hqy	Payments To Settle Client Held Funds PaymentsToSettleClientHeldFunds	215790000	USD
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9754000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8568000	USD
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	394863000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	52422000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	328803000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191726000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11347000	USD
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	6000000	USD
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
CY2020	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1465735000	USD
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-103389000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	137077000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-169749000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	361475000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	225414000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	328803000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191726000	USD
CY2022	us-gaap	Interest Paid Net InterestPaidNet	16107000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	27686000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	21806000	USD
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-5632000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-6022000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9277000	USD
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1414000	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	160000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	487000	USD
CY2022	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-19000	USD
CY2021	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-5438000	USD
CY2020	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0	USD
CY2022	hqy	Exercise Of Stock Options Receivable ExerciseOfStockOptionsReceivable	470000	USD
CY2021	hqy	Exercise Of Stock Options Receivable ExerciseOfStockOptionsReceivable	1478000	USD
CY2020	hqy	Exercise Of Stock Options Receivable ExerciseOfStockOptionsReceivable	0	USD
CY2022	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	USD
CY2021	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	USD
CY2020	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	3776000	USD
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Certain reclassifications have been made to prior year amounts to conform to the current year presentation
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021	us-gaap	Net Income Loss NetIncomeLoss	8834000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	39664000	USD
CY2022	us-gaap	Use Of Estimates UseOfEstimates	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management has made estimates for the allowance for doubtful accounts, capitalized software development costs, evaluating goodwill and long-lived assets for impairment, useful lives of property and equipment and intangible assets, accrued compensation, accrued liabilities, grant date fair value of stock options and performance restricted stock units and restricted stock awards, and income taxes. Actual results could differ from those estimates.
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-44289000	USD
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1427000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83133000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74235000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67026000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	83133000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74235000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67026000	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1444000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	83133000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75679000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	68453000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2400000	USD
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1800000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	6200000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4200000	USD
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3300000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3400000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1000000	USD
CY2022Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	39300000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	27500000	USD
CY2022	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	4300000	USD
CY2020	us-gaap	Depreciation Depreciation	8900000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	10500000	USD
CY2021Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4100000	USD
CY2020	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1900000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	58972000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	60093000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	35600000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	30987000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23372000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29106000	USD
CY2022	us-gaap	Depreciation Depreciation	14700000	USD
CY2021	us-gaap	Depreciation Depreciation	16000000	USD
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.47
CY2022Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1300000	USD
CY2022	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1501000	USD
CY2021	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1045000	USD
CY2020	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	5905000	USD
CY2022	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	1692000	USD
CY2021	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	0	USD
CY2020	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	27760000	USD
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	10832000	USD
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1118000	USD
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	40810000	USD
CY2022	hqy	Other Nonoperating Income Expense Miscellaneous OtherNonoperatingIncomeExpenseMiscellaneous	1708000	USD
CY2021	hqy	Other Nonoperating Income Expense Miscellaneous OtherNonoperatingIncomeExpenseMiscellaneous	5080000	USD
CY2020	hqy	Other Nonoperating Income Expense Miscellaneous OtherNonoperatingIncomeExpenseMiscellaneous	-1934000	USD
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5931000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0429
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5007000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9079000	USD
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4000000	USD
CY2022	hqy	Lessee Operating Lease Number Of Extensions LesseeOperatingLeaseNumberOfExtensions	1	extension
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	14762000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	16073000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	9059000	USD
CY2022	us-gaap	Sublease Income SubleaseIncome	1836000	USD
CY2021	us-gaap	Sublease Income SubleaseIncome	1799000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	750000	USD
CY2022	us-gaap	Lease Cost LeaseCost	12926000	USD
CY2021	us-gaap	Lease Cost LeaseCost	14274000	USD
CY2020	us-gaap	Lease Cost LeaseCost	8309000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y3M25D
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y7D
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0432
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	92529000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	107150000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	15126000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	18889000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	77403000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	88261000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12171000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14037000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	65232000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	74224000	USD
CY2022Q1	hqy	Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount	4500000	USD
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	14742000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	12941000	USD
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	586000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	17480000	USD
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	11200000	USD
CY2022Q1	hqy	Disposal Group Including Discontinued Operation Operating Lease Right Of Use Asset DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAsset	3900000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1289854000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	962752000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	316717000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	195749000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	973137000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	767003000	USD
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	122500000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	99900000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	46500000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	137139000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	120589000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	93822000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	71863000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	67368000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	482356000	USD
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	973137000	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	318600000	USD
CY2022Q1	hqy	Interest On Long Term Debt To Be Paid Year One InterestOnLongTermDebtToBePaidYearOne	33951000	USD
CY2022Q1	hqy	Interest On Long Term Debt To Be Paid Year Two InterestOnLongTermDebtToBePaidYearTwo	33708000	USD
CY2022Q1	hqy	Interest On Long Term Debt To Be Paid Year Three InterestOnLongTermDebtToBePaidYearThree	33467000	USD
CY2022Q1	hqy	Interest On Long Term Debt To Be Paid Year Four InterestOnLongTermDebtToBePaidYearFour	32965000	USD
CY2022Q1	hqy	Interest On Long Term Debt To Be Paid Year Five InterestOnLongTermDebtToBePaidYearFive	30764000	USD
CY2022Q1	hqy	Interest On Long Term Debt To Be Paid After Year Five InterestOnLongTermDebtToBePaidAfterYearFive	72975000	USD
CY2022Q1	hqy	Interest On Long Term Debt To Be Paid InterestOnLongTermDebtToBePaid	237830000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	12527000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	10501000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	10849000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	11094000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	11344000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	40671000	USD
CY2022Q1	hqy	Lessee Operating Lease Liability To Be Paid Including Leases Not Yet Commenced LesseeOperatingLeaseLiabilityToBePaidIncludingLeasesNotYetCommenced	96986000	USD
CY2022Q1	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	25243000	USD
CY2022Q1	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	13191000	USD
CY2022Q1	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	6137000	USD
CY2022Q1	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	5516000	USD
CY2022Q1	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear	6500000	USD
CY2022Q1	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	0	USD
CY2022Q1	us-gaap	Other Commitment OtherCommitment	56587000	USD
CY2022Q1	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	140471000	USD
CY2022Q1	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	74900000	USD
CY2022Q1	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	67953000	USD
CY2021Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	16408000	USD
CY2022Q1	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	75825000	USD
CY2022Q1	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	328608000	USD
CY2022Q1	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	713646000	USD
CY2022Q1	us-gaap	Contractual Obligation ContractualObligation	1401403000	USD
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	950000000	USD
CY2022	hqy	Sublease Income To Be Received SubleaseIncomeToBeReceived	2200000	USD
CY2022Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	30000000	USD
CY2018Q2	hqy	Loss Contingency Number Of Lawsuits LossContingencyNumberOfLawsuits	2	lawsuit
CY2018Q3	hqy	Loss Contingency Number Of Lawsuits LossContingencyNumberOfLawsuits	2	lawsuit
CY2022Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	950000000	USD
CY2021Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1003125000	USD
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	19173000	USD
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	62500000	USD
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	930827000	USD
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	986717000	USD
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	8750000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	922077000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	924217000	USD
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	19200000	USD
CY2021Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	16400000	USD
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	628000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	181000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-448000	USD
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	239000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	258000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	274000	USD
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	867000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	439000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-174000	USD
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-21197000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1630000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3538000	USD
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2122000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3503000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	127000	USD
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-23319000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5133000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3665000	USD
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-22452000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4694000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3491000	USD
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-14016000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	869000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	9063000	USD
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3733000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-99000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	960000	USD
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-165000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	469000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	798000	USD
CY2022	hqy	Effective Income Tax Rate Reconciliation Tax Expense Benefit Employee Remuneration Payments Amount EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitEmployeeRemunerationPaymentsAmount	1214000	USD
CY2021	hqy	Effective Income Tax Rate Reconciliation Tax Expense Benefit Employee Remuneration Payments Amount EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitEmployeeRemunerationPaymentsAmount	1186000	USD
CY2020	hqy	Effective Income Tax Rate Reconciliation Tax Expense Benefit Employee Remuneration Payments Amount EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitEmployeeRemunerationPaymentsAmount	2117000	USD
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-5098000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-2983000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-4815000	USD
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	4218000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2195000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2296000	USD
CY2022	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	836000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	511000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	491000	USD
CY2022	hqy	Effective Income Tax Rate Reconciliation Nondeductible Expense Acquisition Related Costs EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionRelatedCosts	0	USD
CY2021	hqy	Effective Income Tax Rate Reconciliation Nondeductible Expense Acquisition Related Costs EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionRelatedCosts	0	USD
CY2020	hqy	Effective Income Tax Rate Reconciliation Nondeductible Expense Acquisition Related Costs EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionRelatedCosts	3032000	USD
CY2022	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0	USD
CY2021	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0	USD
CY2020	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	5790000	USD
CY2022	hqy	Effective Income Tax Rate Reconciliation Reclassification Of Operating Lease Right Of Use Assets EffectiveIncomeTaxRateReconciliationReclassificationOfOperatingLeaseRightOfUseAssets	0	USD
CY2021	hqy	Effective Income Tax Rate Reconciliation Reclassification Of Operating Lease Right Of Use Assets EffectiveIncomeTaxRateReconciliationReclassificationOfOperatingLeaseRightOfUseAssets	185000	USD
CY2020	hqy	Effective Income Tax Rate Reconciliation Reclassification Of Operating Lease Right Of Use Assets EffectiveIncomeTaxRateReconciliationReclassificationOfOperatingLeaseRightOfUseAssets	0	USD
CY2022	hqy	Effective Income Tax Rate Reconciliation Change In Net Operating Losses EffectiveIncomeTaxRateReconciliationChangeInNetOperatingLosses	0	USD
CY2021	hqy	Effective Income Tax Rate Reconciliation Change In Net Operating Losses EffectiveIncomeTaxRateReconciliationChangeInNetOperatingLosses	377000	USD
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.336
CY2020	hqy	Effective Income Tax Rate Reconciliation Change In Net Operating Losses EffectiveIncomeTaxRateReconciliationChangeInNetOperatingLosses	0	USD
CY2022	hqy	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Changein Deferred Tax Rate EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017ChangeinDeferredTaxRate	725000	USD
CY2021	hqy	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Changein Deferred Tax Rate EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017ChangeinDeferredTaxRate	-1814000	USD
CY2020	hqy	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Changein Deferred Tax Rate EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017ChangeinDeferredTaxRate	225000	USD
CY2022	hqy	Effective Income Tax Rate Reconciliation Return To Provision Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments	810000	USD
CY2021	hqy	Effective Income Tax Rate Reconciliation Return To Provision Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments	1010000	USD
CY2020	hqy	Effective Income Tax Rate Reconciliation Return To Provision Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments	332000	USD
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	3457000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-145000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	93000	USD
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-644000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-45000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-55000	USD
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-22452000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4694000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3491000	USD
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.134
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.081
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5542000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1653000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	14778000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	12600000	USD
CY2022Q1	hqy	Deferred Tax Assets Tax Credit Carryforwards Research Noncurrent DeferredTaxAssetsTaxCreditCarryforwardsResearchNoncurrent	13351000	USD
CY2021Q1	hqy	Deferred Tax Assets Tax Credit Carryforwards Research Noncurrent DeferredTaxAssetsTaxCreditCarryforwardsResearchNoncurrent	6274000	USD
CY2022Q1	hqy	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	19356000	USD
CY2021Q1	hqy	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	21813000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	7729000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	10591000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	3728000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1755000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	64484000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	54686000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3561000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	104000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	60923000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	54582000	USD
CY2022Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1862000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	4946000	USD
CY2022Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	119048000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	134442000	USD
CY2022Q1	hqy	Deferred Tax Liabilities Incremental Contract Costs DeferredTaxLiabilitiesIncrementalContractCosts	9585000	USD
CY2021Q1	hqy	Deferred Tax Liabilities Incremental Contract Costs DeferredTaxLiabilitiesIncrementalContractCosts	6385000	USD
CY2022Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	16923000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	22285000	USD
CY2022Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	11481000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	6081000	USD
CY2022Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	1870000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	172000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	160769000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	174311000	USD
CY2022Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	99846000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	119729000	USD
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3600000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	100000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11700000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10200000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	10800000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	9400000	USD
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	1400000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10206000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9370000	USD
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	240000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	0	USD
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	38000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1000	USD
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1169000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	835000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11653000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10206000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	11653000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10206000	USD
CY2022Q1	hqy	Unrecognized Tax Benefits Amount Netted Against Deferred Tax Assets UnrecognizedTaxBenefitsAmountNettedAgainstDeferredTaxAssets	7097000	USD
CY2021Q1	hqy	Unrecognized Tax Benefits Amount Netted Against Deferred Tax Assets UnrecognizedTaxBenefitsAmountNettedAgainstDeferredTaxAssets	9574000	USD
CY2022Q1	hqy	Unrecognized Tax Benefit Net UnrecognizedTaxBenefitNet	4556000	USD
CY2021Q1	hqy	Unrecognized Tax Benefit Net UnrecognizedTaxBenefitNet	632000	USD
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	700000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	200000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	100000	USD
CY2022Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	1500000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	800000	USD
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	53092000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42863000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45424000	USD
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	53092000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42863000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45424000	USD
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	23.68
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	25.97
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1674000	shares
CY2021Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	1.25
CY2021Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	82.39
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	31.46
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	87164000	USD
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	442000	shares
CY2022	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercised ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised	1.25
CY2022	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercised ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised	44.53
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	19.81
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1232000	shares
CY2022Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	1.25
CY2022Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	82.39
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	35.64
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y2M12D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	25719000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1232000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	35.64
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P4Y2M12D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	25719000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1148000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	33.09
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	25719000	USD
CY2022	hqy	Self Insurance Maximum Coverage Per Incident SelfInsuranceMaximumCoveragePerIncident	350000	USD

Files In Submission

Name	View Source	Status
0001428336-22-000009-index-headers.html	Edgar Link	pending
0001428336-22-000009-index.html	Edgar Link	pending
0001428336-22-000009.txt	Edgar Link	pending
0001428336-22-000009-xbrl.zip	Edgar Link	pending
a1017trittschuhemploymenta.htm	Edgar Link	pending
a1018amendmentno1totrittsc.htm	Edgar Link	pending
a1033non-employeedirectorc.htm	Edgar Link	pending
exhibit2112022-1x31.htm	Edgar Link	pending
exhibit2312022-1x31.htm	Edgar Link	pending
exhibit3112022-1x31ceo.htm	Edgar Link	pending
exhibit3122022-1x31cfo.htm	Edgar Link	pending
exhibit3212022-1x31ceo.htm	Edgar Link	pending
exhibit3222022-1x31cfo.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hqy-20220131.htm	Edgar Link	pending
hqy-20220131.xsd	Edgar Link	pending
hqy-20220131_cal.xml	Edgar Link	unprocessable
hqy-20220131_def.xml	Edgar Link	unprocessable
hqy-20220131_g1.jpg	Edgar Link	pending
hqy-20220131_htm.xml	Edgar Link	completed
hqy-20220131_lab.xml	Edgar Link	unprocessable
hqy-20220131_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HQY
HEALTHEQUITY, INC. Stock $hqy

2022 Q1 Form 10-K Financial Statement

#000142833622000009 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY HEALTHEQUITY, INC. Stock $hqy

2022 Q1 Form 10-K Financial Statement

#000142833622000009 Filed on March 31, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY
HEALTHEQUITY, INC. Stock $hqy